Ardeparin Subcutaneous and Hydrocodone Extended-Release Capsules
Determining the interaction of Ardeparin Subcutaneous and Hydrocodone Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Hydrocodone Extended-Release Tablets
- Ardeparin Subcutaneous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Ardeparin Subcutaneous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Ardeparin Subcutaneous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Ardeparin Subcutaneous-Hydrocortisone
- Ardeparin Subcutaneous-Hydrocortisone (Systemic)
- Hydrocodone Extended-Release Capsules-Aredia
- Hydrocodone Extended-Release Capsules-Arestin
- Hydrocodone Extended-Release Capsules-Arestin eent
- Hydrocodone Extended-Release Capsules-Arestin mucous membrane powder
- Hydrocodone Extended-Release Capsules-Arformoterol
- Hydrocodone Extended-Release Capsules-Arformoterol inhalation